Karim Vermaelen

9PUBLICATIONS
94CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
Inherited human TFIIIA deficiency disrupts T cell development.

|May 07, 2026
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy.

|Oct 30, 2024
Defining the optimal setting for transcriptomic analyses on blood samples for response prediction in immunotherapy-treated NSCLC patients.

Álvaro Marcos Rubio, Seoyeon Oh, Sofie Roelandt

|Aug 03, 2023
Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer.

Alvaro Marcos Rubio, Celine Everaert, Eufra Van Damme

|Apr 23, 2022
Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome.

Malaïka Van der Linden, Bram Van Gaever, Lennart Raman

|Jun 29, 2021
Publisher Correction: The RNA Atlas expands the catalog of human non-coding RNAs.

Lucia Lorenzi, Hua-Sheng Chiu, Francisco Avila Cobos

Pageof 2

Frequent Collaborators

3 joint publications

Tom Taghon

3 joint publications

Katleen De Preter

2 joint publications

Stijn J De Keukeleire

2 joint publications

Tijl Vermassen